FRONT IMMUNOL 润色咨询

Frontiers in Immunology

出版年份:2014 年文章数:22393 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:11.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-05-27 ms2000000510079560 来自布加勒斯特

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:炎症
    经验分享:效率是真的高,服务是真的好,价格也是真的贵。
    顺便问一句,大家担不担心被中科院预警,我很担心。。。

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2021-11-21 科研小王子66

    审稿速度:3.0
    偏重的研究方向:免疫;肿瘤免疫
    经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?

    21

    展开21条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2022-09-07 ms5000001852951271

    偏重的研究方向:biomarker
    经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-06-13 超级敏感型 来自北京

    请问纯生信的还接收吗

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2024-01-20 ms1000001045383040 来自山东省

    返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-10-27 ms4000001836130031 来自吉林省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:综述
    经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-05-19 14853348m56暂无昵称 来自上海

    很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-10-19 ms6000001878152948 来自黑龙江省

    我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-05-09 小小小天才大大大梦想 来自湖南省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:疫苗导致疾病
    经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向:biomarker<br>经验分享:请问在EA阶段,已经一周了,一直没有更新,显示review is ongoing,这个是百分百拒稿了么?百度结果好像是暗示拒稿,很慌,求大佬们解答,谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件,请问大家返修提交上传后都不会收到邮件吗?不确定是否提交对地方,很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综述<br>经验分享:想请教下大家,10月9投,10.19第一个审稿人意见回来了,10.24编辑开放了论坛,但是只有一个审稿人意见,给了两周时间修改,这是什么意思呀?被拒的征兆吗?有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了,review finalized阶段一直没反应,两个审稿人同意发表,不知道还要等多久。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疫苗导致疾病<br>经验分享:今年一月份投稿,二月份编辑送外审,4月份审稿人回复大修,按要求大修10天后审稿人非常爽快的同意发表,一周后主编拒绝,理由是不符合杂志定位,然后给我推荐了另外一个frontiers旗下的杂志,我进去看了一下,我觉得这个杂志才是真不符合,我也是服了,不知道是这位主编水平不行,还是碰到了一个故意刁难中国人的主编,气死!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2165030, encodeId=158a2165030ec, content=偏重的研究方向:免疫<br>经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b025482060, createdName=ms1000001337755817, createdTime=Thu Oct 26 14:11:14 CST 2023, time=2023-10-26, status=1, ipAttribution=)]
    2023-10-26 ms1000001337755817

    偏重的研究方向:免疫
    经验分享:投稿两周了,还没分配学术编辑,这正常吗?没有投特刊。

    4

    展开4条回复
共500条页码: 2/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分